Ovid Therapeutics
OVID
OVID
81 hedge funds and large institutions have $153M invested in Ovid Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+4
Holders Change %
+5.19%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
28
Reduced
23
Closed
8
Calls
$28K
Puts
$1K
Net Calls
+$27K
Net Calls Change
+$19K
Top Buyers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$680K |
| 3 |
Millennium Management
New York
|
+$445K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$415K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$351K |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$9.14M |
| 2 |
Morgan Stanley
New York
|
-$512K |
| 3 |
BlackRock
New York
|
-$380K |
| 4 |
VPC
Vestal Point Capital
New York
|
-$275K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$248K |
